109 related articles for article (PubMed ID: 2074443)
1. Priming effect of orally administered muramyl dipeptide on induction of endogenous tumor necrosis factor.
Okutomi T; Inagawa H; Nishizawa T; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1990 Dec; 9(6):564-9. PubMed ID: 2074443
[TBL] [Abstract][Full Text] [Related]
2. Endogenous production of tumor necrosis factor in normal mice and human cancer patients by interferons and other cytokines combined with biological response modifiers of bacterial origin.
Satoh M; Inagawa H; Shimada Y; Soma G; Oshima H; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):512-24. PubMed ID: 2445926
[TBL] [Abstract][Full Text] [Related]
3. Modulation of lipopolysaccharide-induced cytokine gene expression in mouse bone marrow-derived macrophages by muramyl dipeptide.
Le Contel C; Temime N; Charron DJ; Parant MA
J Immunol; 1993 May; 150(10):4541-9. PubMed ID: 8482846
[TBL] [Abstract][Full Text] [Related]
4. TNF induces endogenous TNF in vivo: the basis of EET therapy as a combination of rTNF together with endogenous TNF.
Inagawa H; Oshima H; Soma G; Mizuno D
J Biol Response Mod; 1988 Dec; 7(6):596-607. PubMed ID: 3216223
[TBL] [Abstract][Full Text] [Related]
5. [Activation of the production of the tumor-necrosis factor by the combined action of lipopolysaccharide and muramyl dipeptide in vitro and in vivo].
Fuks BB; Rakhmilevich AL; Pimenov AA; Dubrovskaia AG
Biull Eksp Biol Med; 1987 Oct; 104(10):497-9. PubMed ID: 3315036
[TBL] [Abstract][Full Text] [Related]
6. Priming of human monocytes with PAF augments their production of tumor necrosis factor.
Rola-Pleszczynski M
J Lipid Mediat; 1990; 2 Suppl():S77-82. PubMed ID: 2133286
[TBL] [Abstract][Full Text] [Related]
7. Production of tumor necrosis factor in nude mice by muramyl peptides associated with bacterial vaccines.
Noso Y; Parant M; Parant F; Chedid L
Cancer Res; 1988 Oct; 48(20):5766-9. PubMed ID: 3167834
[TBL] [Abstract][Full Text] [Related]
8. Macrophage activation by muramyl dipeptide bound to neoglycoproteins and glycosylated polymers: cytotoxic factor production.
Petit C; Monsigny M; Roche AC
J Biol Response Mod; 1990 Feb; 9(1):33-43. PubMed ID: 2319259
[TBL] [Abstract][Full Text] [Related]
9. Improvement of normothermic rat liver ischemia/reperfusion by muramyl dipeptide.
Cursio R; Gugenheim J; Panaia-Ferrari P; Lasfar A; Tovey M; Chastanet S; Saint-Paul MC; Ferré C; Mouiel J
J Surg Res; 1998 Dec; 80(2):339-44. PubMed ID: 9878335
[TBL] [Abstract][Full Text] [Related]
10. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
Fidler IJ; Schroit AJ
J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
[TBL] [Abstract][Full Text] [Related]
11. Role of in vivo scavenger function of macrophages in priming for endogenous production of tumor necrosis factor.
Satoh M; Oshima H; Abe S; Yamazaki M; Mizuno D
J Biol Response Mod; 1987 Oct; 6(5):499-511. PubMed ID: 3681345
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of neoglycoprotein-conjugated muramyl dipeptide against Leishmania donovani infection: the role of cytokines.
Sarkar K; Das PK
J Immunol; 1997 Jun; 158(11):5357-65. PubMed ID: 9164956
[TBL] [Abstract][Full Text] [Related]
13. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors.
Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT
Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671
[TBL] [Abstract][Full Text] [Related]
14. Selective activation of antitumor activity of macrophages by the delivery of muramyl dipeptide using a novel polynucleotide-based carrier recognized by scavenger receptors.
Srividya S; Roy RP; Basu SK; Mukhopadhyay A
Biochem Biophys Res Commun; 2000 Feb; 268(3):772-7. PubMed ID: 10679281
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of experimental liver tumor growth in mice by liposomes containing a lipophilic muramyl dipeptide derivative.
Phillips NC; Tsao MS
Cancer Res; 1989 Feb; 49(4):936-9. PubMed ID: 2912563
[TBL] [Abstract][Full Text] [Related]
16. [Role of tumor necrosis factor in lethality during endotoxic shock in mice presensitized with serum of tumor-bearing mice].
Shapoval AI
Biull Eksp Biol Med; 1993 Jan; 115(1):57-9. PubMed ID: 8054581
[TBL] [Abstract][Full Text] [Related]
17. Induction of tumor necrosis factor-alpha in solid tumor region by the orally administered synthetic muramyl dipeptide analogue, romurtide.
Ueda H; Yamazaki M
Int Immunopharmacol; 2001 Jan; 1(1):97-104. PubMed ID: 11367521
[TBL] [Abstract][Full Text] [Related]
18. Induction of colony-stimulating activity (CSA) by a synthetic muramyl peptide (MDP): synergism with LPS and activity in C3H/HeJ mice and in endotoxin-tolerized mice.
Galelli A; Chedid L
J Immunol; 1986 Nov; 137(10):3211-5. PubMed ID: 3490515
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of induction of endogenous tumor necrosis factor in ascites of ovarian cancer patients by OK-432, a streptococcal preparation.
Mori H; Itoh N; Tamaya T
Immunopharmacol Immunotoxicol; 1989; 11(1):33-53. PubMed ID: 2503555
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of serum antibody production in mice by oral administration of lipophilic derivatives of muramyl peptides and bacterial lipopolysaccharides with bovine serum albumin.
Ogawa T; Kotani S; Shimauchi H
Methods Find Exp Clin Pharmacol; 1986 Feb; 8(2):117-25. PubMed ID: 3713372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
